BridgeBio Pharma's total assets for Q3 2025 were $998.25M, a decrease of -7.59% from the previous quarter. BBIO total liabilities were $2.92B for the fiscal quarter, a 2.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.